This event has ended. Recordings of the event are available to watch below.
On Friday 31 May 2024, we held the Pulmonary Hypertension Question Time webinar. This was an online webinar where a group of experts in pulmonary hypertension explored key questions around the condition, including causes, symptoms, treatment and clinical trials. Ahead of the event, we shared a series of six videos from experts that we invite you to watch.
Hall Skaara, a Norwegian national, was diagnosed with Idiopathic Pulmonary Arterial Hypertension in 2005. He holds a master’s degree in computer science and previously worked at a large international computer company. In 2012, he retired from his regular job and is now a project manager at PHA Europe. His responsibilities include advocacy and managing the Bel Air Center, among other tasks.
Dr. Jason Weatherald is a pulmonologist and Associate Professor at the University of Alberta where he works in the Lung Transplant and Pulmonary Hypertension programs. His research involves risk assessment methods in pulmonary arterial hypertension and patient-oriented research, with a current interest in novel clinical trial designs. He is an Associate Editor at the European Respiratory Journal and at the European Respiratory Review.
Dr Jean-Luc Vachiéry is the Director of the Pulmonary Vascular Diseases and Heart Failure Clinic in the Department of Cardiology at the Erasme University Hospital, Brussels, Belgium.
Dr Lucilla Piccari, M.D., Ph.D. is a pulmonologist at the pulmonary hypertension unit in Hospital del Mar (Barcelona, Spain), where she coordinates the Spanish Registry of Pulmonary Hypertension in Lung Disease (Registro Español de Hipertensión pulmonar Asociada a enfermedad Respiratoria, REHAR). She is the Director of the Pulmonary Vascular Research Program at the Spanish Pulmonology and Thoracic Surgery Society (SEPAR).
This event was organised with the support of the ELF Pulmonary Hypertension Patient Advisory Group (PAG). Find out more about our PAGs here.
ELF does not charge for its events and materials. We want to make sure they are available to anybody who wishes to join or use them. To ensure we can keep doing this we ask that those who can afford to pay to make a donation.
We are grateful to everyone who supports us in this way and helps lung health patients to understand more about their condition and have their voices heard.
